Hjem › Livmoderhalskræft
Livmoderhalskræft kliniske forsøg rekrutterer i USA
114 studier for Livmoderhalskræft rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX34 studier
- Nashville, TN19 studier
- New York City, NY19 studier
- Boston, MA18 studier
- Arlington, VA16 studier
- Los Angeles, CA16 studier
- San Antonio, TX14 studier
- St. Louis, MO13 studier
- Dallas, TX13 studier
- Orlando, FL12 studier
- Chicago, IL12 studier
- Columbus, OH11 studier
- Atlanta, GA11 studier
- Baldwin Park, CA11 studier
- Philadelphia, PA10 studier
- San Diego, CA10 studier
- Edison, NJ10 studier
- Cleveland, OH10 studier
- Queens, NY10 studier
- Durham, NC9 studier
- Portland, OR9 studier
- Washington, DC9 studier
- Miami, FL9 studier
- Minneapolis, MN9 studier
- Birmingham, AL8 studier
- Baltimore, MD8 studier
- Rochester, MN7 studier
- New Orleans, LA7 studier
- Seattle, WA7 studier
- Denver, CO7 studier
- Jacksonville, FL7 studier
- Oklahoma City, OK7 studier
- Pittsburgh, PA7 studier
- San Francisco, CA6 studier
- Grand Rapids, MI6 studier
- New Haven, CT6 studier
- Santa Monica, CA6 studier
- Salt Lake City, UT6 studier
- Austin, TX6 studier
- Cincinnati, OH5 studier
Efter delstat
- Alabama9 studier
- Arizona8 studier
- Arkansas3 studier
- Californien38 studier
- Colorado12 studier
- Connecticut9 studier
- District of Columbia5 studier
- Florida29 studier
- Georgia15 studier
- Illinois15 studier
- Indiana5 studier
- Iowa5 studier
- Kansas3 studier
- Kentucky7 studier
- Louisiana8 studier
- Maryland12 studier
- Massachusetts19 studier
- Michigan14 studier
- Minnesota18 studier
- Mississippi3 studier
- Missouri13 studier
- Nebraska4 studier
- Nevada5 studier
- New Jersey13 studier
- New Mexico4 studier
- New York23 studier
- North Carolina14 studier
- Ohio24 studier
- Oklahoma11 studier
- Oregon10 studier
- Pennsylvania15 studier
- Rhode Island4 studier
- South Carolina6 studier
- Tennessee21 studier
- Texas45 studier
- Utah10 studier
- Virginia20 studier
- Washington10 studier
- West Virginia3 studier
- Wisconsin7 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06465069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
RekruttererFase 1
Alder 18 og opefter · Kvinder · Opdateret 1. okt. 2026 · NCT07292818A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RekruttererObservationsstudie
Alder 18 og opefter · Kvinder · Opdateret 29. sep. 2026 · NCT05051722DESTINY-PANTUMOUR04
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RekruttererFase 4
Alder 18 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT07216703A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT06814496Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05983432A Study of Ivonescimab in People With Endometrial and Cervical Cancers
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 21. sep. 2026 · NCT06925724Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT04038619A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07109726PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 17. sep. 2026 · NCT05758688Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT05475171Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 14. sep. 2026 · NCT04723095GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT04977453Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06535607Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 10. sep. 2026 · NCT04865887Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06293898Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.